TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Aprea Therapeutics AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
181
|
161 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-5,462
|
-58,577
|
-108,816 |
EBITDA |
-5,736
|
-58,555
|
-111,405 |
Total assets |
17,731
|
16,894
|
59,210 |
Current assets |
17,624
|
16,794
|
58,984 |
Current liabilities |
8,089
|
8,994
|
41,820 |
Equity capital |
9,642
|
7,900
|
16,329 |
- share capital |
9,642
|
9,003
|
9,282 |
Employees (average) |
1
|
6
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.4%
|
46.8%
|
27.6% |
Turnover per employee |
0
|
30
|
18 |
Profit as a percentage of turnover |
-32363.0%
|
-67587.6% | |
Return on assets (ROA) |
-30.8%
|
-346.7%
|
-183.8% |
Current ratio |
217.9%
|
186.7%
|
141.0% |
Return on equity (ROE) |
-56.6%
|
-741.5%
|
-666.4% |
Change turnover |
-193
|
25
|
6 |
Change turnover % |
-100%
|
16%
|
4% |
Chg. No. of employees |
-5
|
-3
|
0 |
Chg. No. of employees % |
-83%
|
-33%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.